BOSTON, Massachusetts, July 10 -- Massachusetts General Hospital issued the following news release:

Liquid, or blood-based, biopsies are one of the most eagerly awaited new technologies in cancer care. It is hoped that doctors will be able to use these, in place of tissue samples, to diagnose cancer, match tumors to treatment regimens, and monitor therapy response in real-time. That would mean more patients could be tested without side effects from invasive needle biopsies.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products